Skip to main content
Clinical Trials/CTRI/2024/08/072039
CTRI/2024/08/072039
Not yet recruiting
Phase 3

Effect of timing of oxytocin administration in third stage of labor - nil

nil0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Sponsor
nil
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
nil

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria
  • The following women undergoing vaginal birth will be eligible for enrollment in the study:
  • Gestation greater than 35 weeks of gestation
  • Singleton gestation
  • Last Hb during pregnancy more than 8\.0 gm/dl

Exclusion Criteria

  • Pregnant women with coagulopathy and bleeding disorder
  • Pregnant women with APH (Placenta previa, placental abruption, uterine rupture and vasa previa)
  • Fetal distress
  • Severe FGR (fetal growth retardation

Outcomes

Primary Outcomes

Not specified

Similar Trials